RENAL LECTURE NOTES Flashcards

(99 cards)

1
Q

Blood Vessels

l ___________ – most richly vascularized part;

receives 90% of total renal blood supply

l Renal artery–> interlobar arteries –>arcuate arteries –>interlobular arteries–> l Afferent arterioles enter glomerular tuft; subdivide into 20 to 40 capillary loops

l Capillary loops merge to exit as efferent arterioles

A

Cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the blood flow of the kidney?

A

l Renal artery–> interlobar arteries –>arcuate arteries –>interlobular arteries–> l Afferent arterioles enter glomerular tuft; subdivide into 20 to 40 capillary loops

Note: l Capillary loops merge to exit as efferent arterioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blood Vessels

l Efferent arterioles from superficial nephrons form _____________

A

peritubular vascular network

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

l Deeper juxtamedullary glomeruli give rise to ____________

A

vasa recta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

l Vasa recta descend as straight vessels to supply _____________

A

outer and inner medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

l Anastomosing network of capillaries lined by fenestrated endothelium invested by two layers of epithelium

l Visceral epithelium – part of the capillary wall; separated from endothelial cells by a basement membrane

l Parietal epithelium – lines the urinary space (cavity in which plasma filtrate first collects)

A

Glomeruli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

____________– part of the capillary wall; separated from endothelial cells by a basement membrane

)

A

l Visceral epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

____________ – lines the urinary space (cavity in which plasma filtrate first collects

A

l Parietal epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glomerular capillary wall – filtering membrane and consists of:

A
  1. Endothelial cells
  2. Glomerular basement membrane (GBM)

– lamina densa,

lamina rara interna

and externa

  1. Visceral epithelial cells (podocytes)

– foot processes and filtration slits

  1. Mesangial cells – lie between capillaries; basement membrane-like mesangial matrix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

§ Contractile, phagocytic, capable of proliferation, lay down both matrix and collagen, secrete biologically active mediators

§ Important players in many forms of glomerulonephritis

A

Mesangial cells:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glomeruli Major characteristics of normal glomerular filtration:

A

§ High permeability to water and small solutes

§ Impermeability to proteins (albumin)

– glomerular barrier function (size- and chargedependent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

________________- is important for the maintenance of glomerular barrier function

l Proteins located in slit diaphragm control glomerular permeability

l Mutations in genes encoding proteins give rise to nephrotic syndrome

A

l Visceral epithelial cell (slit diaphragm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_______________

: l Reabsorption of 2/3 of filtered Na, H2O, glucose, K, phosphate, amino acids and proteins

l Vulnerable to ischemic damage

l Toxins are frequently reabsorbed rendering it susceptible to chemical injury

A

Tubules Proximal tubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tubules Juxtaglomerular apparatus:

A

l JG cells – modified smooth muscle cells in the media of afferent arteriole; produce renin

l Macula densa

l Lacis cells or nongranular cells – resemble mesangial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

________- – modified smooth muscle cells in the media of afferent arteriole; produce renin

A

JG cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

_________________– resemble mesangial cells

A

Lacis cells or nongranular cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

l Normal cortex: compact interstitial space occupied by peritubular capillaries and fibroblast-like cells

l Expansion of the cortical interstitium is abnormal (edema or inflammatory cells)

A

Interstitium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

___________– elevation of BUN and creatinine levels;

related to decreased GFR

A

Azotemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

_________– hypoperfusion of the kidneys (hemorrhage, shock, volume depletion, CHF) that impairs renal function in the absence of parenchymal damage

A

l Prerenal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

____________– urine flow obstruction below the level of kidney

A

l Postrenal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

___________

l Azotemia with S/Sx

l Characterized by failure of renal excretory function and metabolic and endocrine alterations

A

Uremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Principal Systemic Manifestations
of CRF and Uremia

Fluid and Electrolytes:

A

l Dehydration
l Edema
l Hyperkalemia
l Metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Calcium Phosphate and Bone:

A

l Hyperphosphatemia

l Hypocalcemia

l Secondary hyperparathyroidism

l Renal osteodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hematologic:______________

A

l Anemia l Bleeding diathesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Cardiopulmonary:
l HPN l CHF l Cardiomyopathy l Pulmonary edema l Uremic pericarditis
26
Gastrointestinal:
l Nausea and vomiting l Bleeding l Esophagitis, gastritis, colitis
27
Neuromuscular: l
 Myopathy l Peripheral neuropathy l Encephalopathy
28
Dermatologic:
l Sallow color l Pruritus l Dermatitis
29
CLINICAL MANIFESTATIONS OF RENAL DISEASES l Acute nephritic syndrome
l Nephrotic syndrome l Rapidly progressive glomerulonephritis – l Acute renal failure – l Chronic renal failure
30
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ – nephritic syndrome with rapid decline (hours to days) in GFR
Rapidly progressive glomerulonephritis
31
\_\_\_\_\_\_\_\_\_\_\_\_\_\_ – oliguria or anuria with recent onset azotemia; can result from glomerular, interstitial, vascular or acute tubular injury
Acute renal failure
32
\_\_\_\_\_\_\_\_\_\_\_ – prolonged S/Sx of uremia; end result of all chronic renal parenchymal diseases
Chronic renal failure
33
Polyuria, nocturia, electrolyte disorders – \_\_\_\_\_\_\_\_\_\_\_\_\_\_
renal tubular defects
34
l Bacteriuria and pyuria – \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
UTI
35
l Renal colic, hematuria – \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
nephrolithiasis
36
l Asymptomatic hematuria or proteinuria \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
– subtle glomerular abnormalities
37
GLOMERULAR DISEASES Primary Glomerulopathies:
l Acute proliferative glomerulonephritis – postinfectious, other l Rapidly progressive (crescentic) glomerulonephritis l Membranous glomerulopathy l Minimal change disease l Focal segmental glomerulosclerosis l Membranoproliferative glomerulonephritis l IgA nephropathy l Chronic glomerulonephritis
38
GLOMERULAR DISEASES Systemic Diseases with Glomerular Involvement:
l SLE l DM l  Amyloidosis l Goodpasture syndrome l Microscopic polyarteritis/polyangiitis l Wegener granulomatosis l Henoch-Schönlein purpura l Bacterial endocarditis
39
GLOMERULAR DISEASES Hereditary Disorders:
l Alport syndrome l Thin basement membrane disease l Fabry disease
40
Clinical Manifestations Glomerular Syndromes:
l Nephritic syndrome l Rapidly progressive glomerulonephritis l Nephrotic syndrome l Chronic renal failure l Isolated urinary abnormalities: hematuria and/or subnephrotic proteinuria
41
Histologic Alterations
l Hypercellularity l Basement membrane thickening l Hyalinization and sclerosis
42
Histologic Alterations - Hypercellularity
l Cellular proliferation of mesangial or endothelial cells l Leukocytic infiltration l Formation of crescents l Proliferating parietal epithelial cells and infiltrating leukocytes l Fibrin as well as tissue factor, IL-1, TNF, interferon- γ elicit crescentic response
43
Histologic Alterations –BM Thickening Light microscopy: l\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Electron microscopy: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Thickening of capillary walls (PAS stain) * l Deposition of amorphous electron-dense material (immune complexes, fibrin, amyloid, cryoglobulins, abnormal fibrillary protein) * l Thickening of the basement membrane in diabetic glomerulosclerosis
44
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Accumulation of homogeneous and eosinophilic materia l l Hyalin - plasma proteins from circulating plasma into glomerular structures l Consequence of endothelial or capillary wall injury; end result of glomerular damage l A common feature of **FSGS**
Hyalinosis:
45
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Accumulation of extracellular collagenous matrix l Mesangium (DM) or capillary loops l May result in obliteration of capillary lumina in affected glomeruli
Sclerosis:
46
\_\_\_\_\_\_\_\_\_ underlie most forms of **primary glomerulopathy** and **many of the secondary glomerular disorders**
Immune mechanisms
47
Immune Mechanisms of Glomerular Injury
l Antibody-Mediated Injury l In Situ Immune Complex Deposition l Circulating Immune Complex Deposition l Cytotoxic Antibodies l Cell-Mediated Immune Injury l Activation of Alternative Complement Pathway (occurs in dense deposit disease)
48
\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l In these forms of injury, antibodies react directly with intrinsic tissue antigen, or antigens "planted" in the glomerulus from the circulation l Anti-GBM antibody induced nephritis l Heymann nephritis (membranous glomerulopathy)
Immune Complex Deposition Involving **Intrinsic and in Situ Renal Antigens**
49
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Antibodies are directed against **intrinsic fixed antigens that are normal components of the GBM prope**r l Anti-GBM antibodies **cross-react** with other BM: Goodpasture syndrome l GBM antigen is a component of the noncollagenous domain of the alpha 3-chain of collagen type IV
Anti-GBM Antibody-Induced Nephritis:
50
l Diffuse **linear staining** for the antibodies by immunofluorescent techniques l Characterized by severe crescentic glomerular damage and the clinical syndrome of RPGN
Anti-GBM Antibody-Induced Nephritis:
51
Immune Complex Deposition Involving Intrinsic and in Situ Renal \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Antibodies react in situ with antigens **not normally present in the glomerulus but are “planted” there** l Cationic molecules; DNA, nucleosomes, other nuclear proteins; bacterial products; large aggregated proteins; immune complexes l **Granular staining** pattern by IF microscopy
Antigens Antibodies against Planted Antigens:
52
\_\_\_\_\_\_\_\_\_\_\_\_\_ l Presence of numerous electron-dense granular deposits (immune reactants) along the subepithelial aspect of basement membrane l Membranous glomerulopathy
Heymann Nephritis:
53
Circulating Immune Complex Nephritis l Glomerular injury is caused by the trapping of circulating Ag-Ab complexes within glomeruli l Abs have no immunologic specificity for glomerular constituents l Complexes localize within the glomeruli due to their physicochemical properties and hemodynamic factors l Antigens that trigger formation of circulating immune complexes may be endogenous (SLE) or exogenous (infections) l Microbial antigens include bacterial products (streptococci), HBsAg, Hepatitis C antigen, antigens of T. pallidum, P. falciparum l Tumor antigens also cause IC-mediated nephritis l In many cases, inciting antigen is unknown
Circulating Immune Complex Nephritis
54
Circulating Immune Complex Nephritis l Glomerulus:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l EM:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l IF: \_\_\_\_\_\_\_\_\_\_\_\_\_\_
* leukocytic infiltration and proliferation of mesangial and endothelial cells * immune complexes as electron-dense deposits (mesangium, subendothelial, subepithelial) * ICs seen as granular deposits along the basement membrane, in mesangium or both
55
Antibodies to Glomerular Cells l Abs to mesangial cell antigens –\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Abs to endothelial cell antigens – \_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Abs to podocyte components – \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
* mesangiolysis and mesangial cell proliferation * endothelial injury and intravascular thrombosis * proteinuria
56
Mechanisms of Progression in Glomerular Diseases Two major histologic characteristics of progressive renal damage:
l Focal segmental glomerulosclerosis l Tubulointerstitial fibrosis
57
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Proteinuria l Sclerosis initiated by the adaptive change that occurs in unaffected glomeruli of diseased kidneys l TGF-ß play a role in induction of sclerosis l Contributing to progressive injury is the inability of podocytes to proliferate after injury
Focal Segmental Glomerulosclerosis
58
\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l Component of many acute and chronic GN l Contributes to progression in both immune and nonimmune glomerular diseases (DM) l Factors that lead to tubulointerstitial injury: ischemia of tubule, acute and chronic inflammation in the adjacent interstitium, damage or loss of the peritubular capillary blood supply
Tubulointerstitial Fibrosis
59
l Hematuria, **red cell casts in the urine,** azotemia, oliguria, **mild to moderate HPN** l Proteinuria and edema l Glomerular diseases presenting with nephritic syndrome are **characterized by inflammation in the glomeruli** l Characteristic of acute proliferative GN and **is an important component of crescentic GN** l **May occur in multisystem diseases: SLE, microscopic polyangiitis**
Nephritic Syndrome
60
l **Diffuse proliferation of glomerular cells** with influx of leukocytes l Caused by immune complexes l Inciting antigen may be exogenous (postinfectious glomerulonephritis) or endogenous (lupus nephritis)
Acute Proliferative (Poststreptococcal, Postinfectious) Glomerulonephritis
61
l Appears **1-4 weeks after a streptococcal infection of pharynx or skin (impetigo)** l Occurs most frequently in children 6-10 years old
Poststreptococcal Glomerulonephritis
62
s Etiology and Pathogenesis: l Group **A ß-hemolytic streptococci** l **Immunologically-mediated** l Elevated titers of Abs against streptococcal antigens l Low serum complement levels (activation and consumption of complement components) l Granular immune deposits in glomeruli and electron dense deposits immune complex mediated mechanism
Poststreptococcal Glomerulonephriti
63
Morphology: l **Enlarged, hypercellular glomeruli** caused by: **infiltration by leukocytes, proliferation of endothelial and mesangial cells, crescent formation** **l Capillary lumen obliteration** **l Interstitial edema and inflammation** **l Tubules with red cell casts**
Poststreptococcal Glomerulonephritis
64
l IF microscopy: granular deposits of IgG, IgM, and C3 in mesangium and along GBM
Poststreptococcal Glomerulonephritis
65
Poststreptococcal Glomerulonephritis Electron Microscopy:
l Discrete, amorphous, electron dense deposits on epithelial side of membrane (“humps”) l Subendothelial, intramembranous and mesangial deposits are also seen Acute proliferative glomerulonephritis. A, Normal glomerulus. B, Glomerular hypercellularity is due to intracapillary leukocytes and proliferation of intrinsic glomerular cells. C, Typical electron-dense subepithelial "hump" and a neutrophil in the lumen.
66
Poststreptococcal Glomerulonephritis Clinical Course:
l Malaise, fever, nausea, oliguria, **hematuria 1-2 weeks after recovery from a sore throat** l Red cell casts in urine, mild proteinuria (\<1 gm/day) l Periorbital edema, mild to moderate HPN l  Elevations of antistreptococcal Ab titers; decline in serum C3 l **95% of affected children recover**
67
l Occurs sporadically in association with bacterial infections (staph endocarditis), viral disease, parasitic infections l Granular immunofluorescent deposits and subepithelial humps are present
Nonstreptococcal Acute Glomerulonephritis (Postinfectious Glomerulonephritis)
68
l A syndrome associated with severe glomerular injury l Characterized clinically by **rapid and progressive loss of renal** function with **severe oliguria and signs of nephritic syndrome** l If untreated, death from renal failure occurs within weeks to months l Most common histologic picture: **crescents in most of the glomeruli**
Rapidly Progressive (Crescentic) Glomerulonephritis
69
Rapidly Progressive (Crescentic) Glomerulonephritis Classification (immunological findings) and Pathogenesis:
l Type I RPGN – anti-GBM antibody-induced disease l Type II RPGN – immune complex-mediated disease l Type III RPGN – pauci-immune type
70
Rapidly Progressive (Crescentic) Glomerulonephritis l **All 3 types** may be associated with a **welldefined renal or extrarenal disease,** but in approximately **50% of cases**, the disorder is idiopathic l The common denominator in all types of RPGN is \_\_\_\_\_\_\_\_\_\_\_\_\_\_
severe glomerular injury
71
Rapidly Progressive (Crescentic) Glomerulonephritis l **Linear deposits of IgG and C3 in the GBM** l **Anti-GBM antibodies cross-react with pulmonary alveolar bm Goodpasture syndrome** l Tx: **Plasmapheresis** to remove circulating Abs combined with steroids and cytotoxic agents l Goodpasture antigen is a peptide within the noncollagenous portion of the α3 chain of collagen type IV
Type I RPGN:
72
Rapidly Progressive (Crescentic) Glomerulonephritis l Can be a **complication of any of the immune complex** nephritides: postinfectious GN, lupus nephritis, IgA nephropathy, Henoch-Schönlein purpura l IF: **granular pattern of staining characteristic of immune complex deposition** l Cellular proliferation within glomerular tuft and crescent formation l Require tx of underlying disease
Type II RPGN:
73
Rapidly Progressive (Crescentic) Glomerulonephritis l Lack of anti-GBM Abs or immune complexes by IF and EM l Most patients have circulating ANCAs that produce cytoplasmic (c) or perinuclear (p) staining patterns l Component of systemic vasculitis – Wegener granulomatosis or microscopic polyangiitis l In many cases, pauci-immune crescentic GN is isolated and hence idiopathic
Type III RPGN:
74
Rapidly Progressive (Crescentic) Glomerulonephritis Morphology:
l Glomeruli: focal necrosis, diffuse or focal endothelial proliferation, mesangial proliferation l Distinctive crescents - obliterate Bowman space and compress the glomerular tuft l Fibrin strands are prominent between the cellular layers in the crescents
75
Rapidly Progressive (Crescentic) Glomerulonephritis Morphology: l EM: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l IF:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
1. ruptures in the GBM; allows leukocytes, proteins and inflammatory mediators to reach urinary space trigger crescent formation 2. granular immune deposits (immune complex-mediated cases); linear fluorescence for Ig and complement (Goodpasture syndrome); little or no deposition (pauci immune)
76
Nephrotic Syndrome - Causes Primary Glomerular Disease: l
 Membranous glomerulopathy l Minimal change disease l Focal segmental glomerulosclerosis l Membranoproliferative glomerulonephritis l Other proliferative glomerulonephritides (focal, pure mesangial, IgA nephropathy)
77
Nephrotic Syndrome - Causes Systemic Diseases:
l DM l Amyloidosis l SLE l Drugs (NSAIDs) l Infections (malaria, syphilis, hepatitis B and C, HIV) l Malignant disease (carcinoma, lymphoma) l Miscellaneous (hereditary nephritis)
78
l Common cause of nephrotic syndrome in **adults** l Diffuse thickening of the glomerular capillary wall and l Accumulation of electron-dense, Igcontaining deposits along the subepithelial side of bm
Membranous Nephropathy
79
Membranous Nephropathy Secondary Membranous Glomerulopathy: occurs in association with other systemic diseases
l Drugs (Penicillamine, Captopril, NSAIDs) l Underlying malignant tumors (carcinomas of lung and colon; melanoma) l SLE l Infections (chronic hepatitis B, hepatitis C, syphilis, schistosomiasis, malaria) l Other autoimmune disorders (thyroiditis) 85% idiopathic
80
Membranous Nephropathy Etiology and Pathogenesis:
l Idiopathic membranous glomerulopathy, **like Heymann nephritis, is considered an autoimmune disease linked to susceptibility genes and caused by antibodies to a renal autoantigen** l C5b-C9 activation of glomerular epithelial and mesangial cells liberate proteases and oxidants capillary wall injury protein leakage
81
Membranous Nephropathy LM:
uniform, diffuse thickening of the glomerular capillary wall
82
Membranous Nephropathy l BM material laid down between IC deposits, appearing as _______________ protruding from the GBM
irregular spikes ## Footnote Note : l Spikes are best seen by silver stains
83
Membranous Nephropathy l EM:
irregular dense deposits of immune complexes between bm and overlying epithelial cells (with **effaced foot processes)**
84
Membranous Nephropathy l IF:
**granular deposits** contain both Igs and complement Characteristic granular immunofluorescent deposits of IgG along GBM.
85
Membranous Nephropathy Clinical Course:
 Begins with** insidious onset of nephrotic syndrome or with non-nephrotic proteinuria (15% of patients)** l Hematuria and mild HPN (15 - 35%) l Nonselective proteinuria l Indolent course l Does not respond well to steroid l Progression is associated with increasing sclerosis of glomeruli, rising serum creatinine and development of HPN
86
l Most frequent cause of nephrotic syndrome in **children** l Peak incidence: between **2 and 6 years** l **Diffuse effacement of foot processes** of **podocytes in glomeruli** that appear virtually **normal by LM** l Sometimes **follows a respiratory infection or routine prophylactic immunization** l Most characteristic feature: r**esponse to corticosteroid therapy**
Minimal Change Disease
87
Minimal Change Disease Pathogenesis:
l MCD involves some immune dysfunction, resulting in the elaboration of a cytokine that **damages podocyte**s and **causes proteinuria** l Nephrotic syndrome resulting from mutations in **nephrin and podocin (localized to the slit** **diaphragm)** illustrates that structural defects of the **podocyte are sufficient to cause marked** **proteinuria** in the absence of an immune injury
88
Minimal Change Disease Morphology: l LM:\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l EM: \_\_\_\_\_\_\_\_\_\_\_\_\_\_ l IF: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
1. glomeruli normal 2. no electron-dense material; uniform and diffuse effacement of foot processes 3. no immunoglobulin or complement deposits
89
Minimal Change Disease Clinical Course:
l** Renal function remains good** despite massive proteinuria l Highly selective proteinuria (albumin) l** Response to corticosteroid therapy** l** Excellent long-term prognosis** l MCD in adults** can be associated with Hodgkin lymphoma** l **Secondary MCD may follow NSAID therapy in association with AIN**
90
l Characterized by **sclerosis of some**, **but not all glomeruli**; in the affected glomeruli, only a portion of the capillary tuft is involved **l Accompanied by nephrotic syndrome** **l Most common cause of nephrotic syndrome in adults in the US**
Focal Segmental Glomerulosclerosis
91
FSGS occurs in the following settings:
l HIV infection, heroin addiction, sickle cell disease, massive obesity l As a secondary event in focal glomerulonephritis (reflecting glomerular scarring) l As a component of adaptive response to loss of renal tissue l In certain inherited forms of nephrotic syndrome **l As a primary disease (idiopathic FSGS)**
92
Clinical signs differ from those of MCD in the following respects:
l Higher incidence of hematuria, reduced GFR, HPN l Proteinuria is more often nonselective l Poor response to steroid l Progression to chronic kidney disease
93
Focal Segmental Glomerulosclerosis Morphology: l EM: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ l IF:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
1. l **Collapse of BMs**, increase in matrix and hyalinosis ``` l **Global sclerosis of glomeruli**, **tubular atrophy** and interstitial fibrosis (with disease progression) ``` 2. sclerotic and nonsclerotic areas show diffuse effacement of foot processes; focal detachment of epithelial cells with denudation of GBM 3. IgM and C3 in the sclerotic areas and/or mesangium
94
Focal Segmental Glomerulosclerosis Collapsing glomerulopathy
l Retraction and/or collapse of glomerular tuft l Proliferation and hypertrophy of podocytes l Tubular microcysts l May be idiopathic but is the most characteristic lesion in HIV-AN l Poor prognosis
95
Focal Segmental Glomerulosclerosis Pathogenesis: l\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_– **hallmark of FSGS due to l Circulating cytokine** l Genetically determined **defects affecting slit diaphragm components** **l Hyalinosis and sclerosis** – entrapment of plasma proteins in extremely hyperpermeable foci and increased ECM deposition
Epithelial damage
96
Focal Segmental Glomerulosclerosis Pathogenesis: l Genetic basis:\_\_\_\_\_\_\_\_\_\_\_- gene in chromosome **19q13 encodes nephrin** – **component of slit diaphragm** – control glomerular permeability l Mutations of this gene give rise t**o congenital nephrotic syndrome of the Finnish type,** **producing minimal change disease-like glomerulopathy**
NPHS1
97
Focal Segmental Glomerulosclerosis Pathogenesis: l **\_\_\_\_\_\_\_\_\_\_\_\_** gene in chromosome 1q25-q31 encodes **podocin** – component of slit diaphragm l Mutations in NPHS2 result in a syndrome of **steroid-resistant nephrotic syndrome of childhood onset** l Podocin mutations may account for **30% of cases of steroid-resistant NS in children**
**NPHS2**
98
Focal Segmental Glomerulosclerosis Clinical Course:
l Little tendency for spontaneous remission in idiopathic FSGS l Variable responses to corticosteroid therapy l Progression of renal failure occurs at variable rates l Recurrences are seen in 25 to 50% of patients receiving allografts
99
Membranoproliferative Glomerulonephritis l Characterized by alterations in the GBM, proliferation of glomerular cells and leukocyte infiltration l Mesangiocapillary GN l May present only with hematuria or proteinuria in the non-nephrotic range or combined nephroticnephritic syndromes l Primary (idiopathic) or secondary l Primary MPGN: types I and II